JAMA study, clinical trials offer fresh hope for kids with rare brain disease
UT Southwestern Medical Center May 10, 2017
A study led by investigators in UT SouthwesternÂs Peter OÂDonnell Jr. Brain Institute offers novel insight into how a newly designed diet can help children cope with Glut1 deficiency  a rare disease that severely inhibits learning and muscle control by starving the brain of glucose, its main energy source. And scientists are already beginning to expand on the findings published in JAMA Neurology journal by testing an edible oil that smaller studies indicate can improve cognitive abilities in patients.
Combining the new diet with the supplemental oil derived from castor beans could provide a life–changing treatment that trail blazes a brighter future for thousands of children in the U.S. who otherwise face a lifetime of stunted brain function.
Patients with Glut1 deficiency usually canÂt learn beyond an elementary school level and often canÂt live independently as adults.
ÂWeÂre talking about helping people be independent from their parents. The question every parent asks is, ÂWill my child be able to have an independent life when weÂre gone? Right now itÂs very questionable whether theyÂll be able to achieve independence, said Dr. Juan Pascual, Associate Professor of Neurology and Neurotherapeutics, Pediatrics, and Physiology at UT Southwestern Medical Center.
Dr. Pascual led the JAMA study that relied on data from a worldwide registry he created in 2013 for Glut1 deficiency patients. The research tracked 181 patients for three years, finding that a modified Atkins diet that includes less fat and slightly more carbohydrates than the standard ketogenic diet helped reduce seizures and improved the patients long–term health. The study also found earlier diagnosis and treatment of the disease improved their prognosis.
In addition, Dr. Pascual is overseeing national clinical trials that are testing whether triheptanoin (C7) oil improves the intellect of patients by providing their brains an alternative fuel to glucose. The trials will last five years and are funded with more than $3 million from the National Institutes of Health.
Go to Original
Combining the new diet with the supplemental oil derived from castor beans could provide a life–changing treatment that trail blazes a brighter future for thousands of children in the U.S. who otherwise face a lifetime of stunted brain function.
Patients with Glut1 deficiency usually canÂt learn beyond an elementary school level and often canÂt live independently as adults.
ÂWeÂre talking about helping people be independent from their parents. The question every parent asks is, ÂWill my child be able to have an independent life when weÂre gone? Right now itÂs very questionable whether theyÂll be able to achieve independence, said Dr. Juan Pascual, Associate Professor of Neurology and Neurotherapeutics, Pediatrics, and Physiology at UT Southwestern Medical Center.
Dr. Pascual led the JAMA study that relied on data from a worldwide registry he created in 2013 for Glut1 deficiency patients. The research tracked 181 patients for three years, finding that a modified Atkins diet that includes less fat and slightly more carbohydrates than the standard ketogenic diet helped reduce seizures and improved the patients long–term health. The study also found earlier diagnosis and treatment of the disease improved their prognosis.
In addition, Dr. Pascual is overseeing national clinical trials that are testing whether triheptanoin (C7) oil improves the intellect of patients by providing their brains an alternative fuel to glucose. The trials will last five years and are funded with more than $3 million from the National Institutes of Health.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries